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Introduction
FoxP3 þ regulatory T (Treg) cells are a subset of CD4 þ T lymphocytes with suppressive activity, key mediator of peripheral tolerance and essential for preventing autoimmune and chronic inflammatory diseases. However, the lack of specific markers and insufficient understanding of Tregs biology constitute the two largest obstacles to develop immunotherapy protocols for the treatment of these diseases [1] . Treg cells inhibit proliferation and function of effector T cells through various mechanisms, including cellecell contact and the production of anti-inflammatory cytokines such as TGF-b or IL-10. Tregs can develop in the thymus, or from naïve CD4 þ T cells in the periphery [2] . After antigen challenge lymph nodes are the sites of differentiation of effector T cells and/or Tregs, which upregulate specific adhesion and chemokine receptors and migrate to the inflamed tissue. This regulatory mechanism of cell migration is critical for a proper balance between the innate and adaptive immune responses in the inflamed tissue [3] . In this regard, S1P 1 has been described as an important molecule controlling lymphocyte egress from lymphoid organs and leukocyte receptor CD69 negatively regulates its expression [4] . The early leukocyte activation antigen CD69 is a membrane receptor from the family of type II C-type lectins. CD69 is rapidly induced after cell activation in all bone marrow derived cells except erythrocytes [5, 6] . Expression of CD69 in vivo is restricted to positively selected thymocytes and leukocytes undergoing activation, particularly at inflammatory sites. Engagement of CD69 with monoclonal antibodies (mAbs) in the presence of phorbol esters induces a strong Ca 2þ influx leading to the activation of ERK, induction of IL-2 and IFN-g genes, and T cell proliferation [7, 8] . However, in vivo studies with CD69-deficient mice revealed an unexpected immunoregulatory role [9] . A mouse model of lymphocyte-dependent collagen-induced arthritis (CIA) suggested that CD69 might act as a regulatory molecule by modulating TGF-b levels at the site of inflammation [10] . Since TGF-b participates in the differentiation both of regulatory T cells and of Th17 cells [11, 12] , CD69 might regulate the immune response at the stage of T cell differentiation. The balance between Th17 and Treg cells is critical for the regulation of the immune response by determining the net balance of pro-and anti-inflammatory cytokines at the inflammatory foci.
In this report we have analyzed the role of CD69 in the function of FoxP3 þ Tregs. We show that around half of the Tregs located in lymphoid organs express CD69 in steady state. CD69 þ Tregs express higher surface levels of suppression-associated markers than CD69 À Tregs cells or Tregs from Cd69 À/À mice, and have enhanced suppressor activity in vitro and in a mouse model of lung tolerance to harmless antigens. Our results strongly support a role for CD69 as a critical receptor for controlling Treg-suppressor function in both physiological and pathological immune responses, including autoimmunity and allergy.
Materials and methods

Animals
CD69-deficient mice were generated as described [13] . C57BL/ 6 Tg(TcraTcrb)425Cbn/J mice expressing a T-cell receptor specific for peptide 323e339 of OVA in the context of I-Ab (OTII mice) were purchased from the Jackson Laboratory (stock number 004194). OTII mice were backcrossed with CD69-deficient mice in the C57BL/ 6 background (OTKO mice). For in vivo tolerogenic asthma experiments, we used females 10e12 weeks old that were either littermates or age-matched offspring in BALB/c or OTII background. Foxp3-RFP reported mice were kindly provided by Dr. R.A. Flavell (Yale University). Mice were kept in SPF conditions at the Animal Facility of CNIC. Experimental procedures were approved by the CNIC Committee for Research Ethics and conducted under Animal Welfare and Health Spanish and European guidelines.
T-cell isolation
Single-cell suspensions were obtained from spleen or mesenteric lymph nodes and incubated with the following biotinylated antibodies: CD8, CD19, B220, MHCII, CD11c, IgM, DX5 and CD11b, followed by streptavidin Microbeads. CD4 þ T cells were negatively selected with auto-MACS Pro (Miltenyi) separator. The negative fraction was incubated with anti-CD25 biotin to obtain Tregs.
Treg cell suppression assays
Tconvs were cultured with coated a-CD3 antibody (1 mg/mL) plus indicated amounts of soluble a-CD28 or irradiated T celledepleted splenocytes. For antigen-specific assays, CD4 þ T cells from OTII and OTKO mice were cultured in the presence of irradiated APC and OVAp (10 mg/mL). T cell proliferation was measured by [ 3 H]-thymidine incorporation for the last 16 h of culture or by CFSE or CellTraceViolet staining of CD4 þ Tconv cells.
Intracellular staining and FACS
Tregs or Tconv cells were treated with 1 mg/ml anti-CD3 (145-2C11) and anti-CD28 (37.51), and crosslinked with antieArmenian
Hamster IgG F(ab')2 (20 mg/mL). Activation was arrested by fixation with 4% formaldehyde and permeabilized with 90% methanol and cells were incubated with phospho-Akt, phospho-Erk and phospho-Stat5 from Cell Signaling.
In vitro differentiation of Tregs
OVA-specific TCR transgenic naïve T cells were obtained from OTII and OTKO mice and cultured for 72 h with irradiated APCs in the presence of 10 mg/ml OVAp, recombinant TGF-b1, and IL-2.
In vitro differentiation of iTregs from C57BL/6 mice with normal TCR was performed from naïve CD4 T cells from CD69-proficient or deficient mice, co-cultured 120 h with WT splenic dendritic cells in the presence of plate-bound CD3 and soluble CD28 plus recombinant TGF-b1 and IL-2.
Tolerogenic challenge with harmless antigen
To analyze the in vivo function of Treg, we used a previously described tolerogenic model [14] . Briefly, at day 0, mice were i.t injected with 800 mg LPS-free OVA (Calbiochem). At day 20, mice received 3 OVA aerosols (10 mg/mL in PBS, generated using a jet nebulizer) of 30 min on 3 consecutive days. In some experiments, 10 days later after the i.t administration of OVA, the mice were immunized with OVA-alum (10 mg OVA adsorbed to 2 mg aluminum hydroxide) and 10 days later, mice were challenged with three daily 30-min OVA aerosols as described before.
Adoptive transfer experiments
Mice were intraperitoneally injected with 10 
In vivo FMT 1500 tomographic imaging and analysis
Mice were injected intravenously with 4 nmol of Neutrophil Elastase 680 FAST (PerkinElmer, Inc.). OVA-challenged and control mice were imaged using the FMT 1500 fluorescence tomography in vivo imaging system (PerkinElmer, Inc.). The collected fluorescence data were reconstructed by FMT 2500 system software version 1.1 for three-dimensional fluorescence quantification. The total amount of lung fluorescence (in picomols) was calculated relative to internal standards. 1D ), indicating that, although Treg development seems not to be affected by the lack of CD69, their function could be dampened.
The suppressive function of Tregs is dependent on CD69 expression
We next assessed the role of CD69 in the suppressive function of Tregs. Naïve conventional T (Tconv) cells from Cd69 2), which downregulates CD69 expression [15] and blocks the suppressive function (Fig. 2D) . It is worth noting that CD69 expression in untreated CD69 þ Treg subpopulation was maintained at high levels in vitro after 3 days of coculture with Tconv cells (Fig. 2 , CeD), indicating that sustained CD69 expression is critical for the suppressive function of Tregs. We also analyzed the ability of Tregs differentiated in vitro (iTreg) to induce effector T cells suppression; although Treg differentiation process is not compromised in OTII Cd69 À/À cells (Fig. 2E ) or in
Cd69
À/À cells with normal TCR (Fig. 2G ), these cells were unable to properly induce T cell suppression compared to OT-II-Cd69 (Fig. 2H ), respectively. These data indicate that CD69 expression is also required for iTreg suppressive function. To further support these results, we analyzed the expression of CD69 in Tregs from Foxp3-RFP reported mice. As in the WT B6 mice, CD69 þ and CD69 À Tregs maintain the same proportions in lymphoid organs and more importantly, Foxp3-RFP þ CD69 À Tregs showed almost no ability to suppress Tconv proliferation (Fig. 2I ).
Activation of CD69 þ Tregs enhances STAT5 phosphorylation and decreases ERK phosphorylation
Activation of STAT5 has been reported to be required for Treg development and suppressive function [16] . To study the molecular mechanism of suppression by FoxP3
þ Tregs, we stimulated sorted Tregs and naïve T cells through the TCR and measured the levels of STAT5, ERK and AKT phosphorylation by FACS. Naïve T cells from Cd69 þ/þ or Cd69 À/À mice showed no significant difference in STAT5, ERK or AKT phosphorylation (Fig. 3A) . However STAT5 phosphorylation in Cd69 À/À Tregs was inhibited, whereas phospho-ERK was enhanced at late time points and AKT activation was unaltered ( Fig. 3B) . These results are consistent with our previous results in Th17 cells, where STAT5 activation is partially inhibited in the absence of CD69 [13] . Addition of IL-2 abolished the differences in STAT5 phosphorylation between Cd69 þ/þ and Cd69 À/À Tregs (Fig. 3C ), thus indicating that this cytokine restores the activation of the pathway.
To further study the role of ERK activation in the suppressor function of Tregs, Tregs isolated from Cd69 þ/þ or Cd69 À/À mice were treated with the ERK inhibitor U0126. ERK inhibition in Tregs from Cd69 À/À mice restored their suppressor activity, whereas it had no detectable effect in Tregs from Cd69 þ/þ mice (Fig. 3D) .
Moreover, sorted CD69 À Tregs and Cd69 À/À Tregs partially recovered their suppressor potential after pre-incubation with U0126 (Fig. 3E ). To assess whether ERK inhibitors could also restore the suppressor potential of Cd69 À/À Tregs in vivo, mice were given daily i.p. injection with the ERK inhibitor ci 1040 [17] . In vivo inhibition of ERK phosphorylation in Cd69 À/À mice ( Supplementary   Fig. S4 ) restored the suppressor capacity of Tregs isolated from Cd69 À/À mice to the level detected for Tregs from Cd69 þ/þ mice (Fig. 3F ).
CD69
þ Tregs display specific cytokine, migratory and Treg cellassociated gene expression
We analyzed the secretion of TGF-b1 and IL-2, cytokines involved in the regulation of T cell proliferation. Sorted Tregs were stimulated with anti-CD3/CD28 mAbs. Cd69 À/À Tregs secreted significantly less TGF-b1 than Cd69 þ/þ Tregs (Fig. 4A) . Moreover, lower levels of soluble TGF-b1 were found in co-cultures of Cd69
Tregs and Tconvs (Fig. 4B ). IL-2 secretion was low in cultures of Cd69 þ/þ and Cd69 À/À Tregs, consistent with the notion that lack of IL-2 secretion is a typical feature of mature and functional Tregs [18] (Fig. 4A ). However we observed increased IL-2 secretion in cocultures of Cd69 À/À Tregs and Tconvs (Fig. 4B) , which could be a consequence of the higher proliferation rate of Tconvs in this condition (Fig. 2, A and B) . Intracellular content of FoxP3 (Fig. 1B , and Supplementary Fig. S3B ) as well as Foxp3 mRNA levels (Fig. 4C ) was the same in CD69 þ , CD69 À and Cd69 À/À Tregs or in iTregs from (Fig. 4D) . Thus the functional differences between CD69 þ and CD69 À Tregs are unrelated to FoxP3 expression.
To identify differential gene expression patterns we conducted TaqMan immune function gene expression analysis on sorted CD69 þ , and CD69 À Tregs (Fig. 4 EeG, and Supplementary   Table S1 ). CD69 þ Tregs showed higher expression of cytokine genes involved in T cell differentiation and function such as Il2, Il10, Il4 and Ifng (Fig. 4E) . Expression of these transcripts was barely detected in CD69 À Tregs. CD69 þ Tregs express higher levels of Cxcl10, Cxcl11 and Ccl5 and chemokine receptors Cxcr3 and Ccr2, involved in the migration of Tregs to inflamed tissue [19] . CD69 À Tregs express low levels of most of the receptors and Errors bars represent mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001. chemokines analyzed (Fig. 4F) . Analysis of surface receptor gene expression showed that CD69 þ and CD69 À Tregs express similar levels of the membrane antigens analyzed ( Supplementary  Fig. S5A ). CD69 þ Tregs expressed high levels of Tbx21 (T-bet), which together with FoxP3 is important for the suppression of immune responses in vivo [20] (Supplementary Fig. S5B ). Interestingly, expression of Icos and FasL, which are involved in immune-suppression pathways, was enhanced in CD69 þ Tregs (Fig. 4G ). These data indicate that CD69 þ Tregs and CD69 À Tregs exist as two independent populations with different pattern of gene expression.
Tregs from Cd69
À/À mice have reduced capacity to maintain immune tolerance and suppress inflammation in vivo
We next investigated the tolerogenic potential of Cd69 þ/þ and Cd69 À/À Tregs in a model of sensitization to inhaled harmless antigens. In this model, primary tolerogenic challenge by intratracheal (i.t.) injection of OVA did not lead to sensitization or lung inflammation upon repeated challenge with aerosolized OVA in CD69 þ/þ mice. However, analysis of bronchoalveolar lavage (BAL)
fluids as previously described [14] showed increased neutrophil and macrophage infiltration in Cd69 À/À mice (Fig. 5A) . Detection of activated neutrophils by tomographic imaging after Neutrophil Elastase probe administration confirmed that only Cd69 À/À mice developed inflammation under tolerogenic conditions, indicating that the absence of CD69 impairs the maintenance of tolerance in lungs (Fig. 5B) . We found higher neutrophil infiltration in Me-LNs from OVA-sensitized Cd69 À/À mice (Fig. 5C ) and this was confirmed by tomographic imaging (Fig. 5D) . Moreover, transgenic OTKO mice fail to establish lung tolerance, compared to OTII, after OVA exposure, similar to CD69 À/À mice in BALB/c background (Fig. 5E) . In a different experiment, after the i.t. tolerogenic challenge, mice were i.p. immunized with OVA, in order to study the induction of tolerance after immunization with the same antigen. After aerosol exposure to OVA mice developed airway inflammation, although the neutrophil infiltration was significantly higher in Cd69 À/À mice than in Cd69 þ/þ mice (Fig. 5F ). Neutrophil infiltration in lungs and tracheas assessed by tomographic imaging was higher in OVA-treated Cd69 À/À mice (Fig. 5G) , indicating that CD69 expression is necessary for the maintenance of tolerance in a mouse model of airway inflammation. The lack of CD69 expression on Tregs diminishes the potential to suppress inflammation in response to inhaled antigens (Fig. 5) . To rule out an effect to differences in cell migration capacities of
Cd69
þ/þ and Cd69 À/À Tregs after OVA challenge, we analyzed the content of CD4 þ FoxP3 þ cells in BALS fluid (Fig. 6A ) and Me-LNs (Fig. 6B ) finding no significant differences in Tregs cell numbers between the two genotypes. Analysis of tracheas by whole mount staining confocal microscopy detected higher numbers of perivascular infiltrating neutrophils in Cd69 À/À mice (Fig. 6C) ; however, we did not observe any differences in total numbers of FoxP3 þ cells migrating to this tissue, indicating that the migration of FoxP3 þ cells is not affected by CD69 expression (Fig. 6D) . Moreover, we analyzed the expression levels of S1P 1 receptor, a molecule involved in T-cell migration regulated by CD69 expression on the membrane [4] . We did not find any differences in S1P 1 receptor expression levels between Cd69 À/À and Cd69 À/À Treg cell subsets ( Supplementary Fig. S6 ).
Cd69 À/À Tregs show impaired function in cell therapy protocols
To demonstrate that CD69 expression on Tregs is required to restore lung homeostasis and suppress inflammation in response to inhaled antigens, we immunized Cd69 þ/þ or Cd69 À/À mice with OVA. MS-LNs were collected and cells were ex-vivo expanded with TGF-b1 and IL-2 in the presence of iAPCs pre-incubated with OVAp. from three biological samples. Errors bars represent mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001. (Fig. 7D) .
To rule out a role in Treg migration, we analyzed CD4 þ Foxp3 þ Treg cells in mediastinal lymph nodes and BALS after adoptive transfer experiment using nTregs. Although we find an increase in Treg numbers from BALS after OVA exposure, we do not detect any significant differences between WT and CD69 À/À mice transferred with CD69 þ or CD69 À nTreg cells ( Supplementary Fig. S7 ), thus confirming our previous results pointing to a dysfunction in CD69 À/ À Tregs rather than a defect in their migration.
Discussion
Here we identify a unique CD69-constitutive expressing subset of Treg cells in homeostatic and inflammatory conditions with [24] or after migration within lymphoid organs [25] and tumor induction [26] , and exert their function mainly through membranebound LAP/TGF-b1. Similarly, recent studies in humans have found the CD69
þ Tregs after allospecific activation in vitro [28] , and the diminished suppressive function of Tregs from systemic sclerosis patients, correlating with lower CD69 expression [29] . FoxP3 has been postulated as a master lineage specification factor for Tregs; however, the data are contradictory, with some groups postulating that FoxP3 þ T cells are a suppressive population [30] and others describing an incomplete suppressive function in this population [31e33] . Our data reveal that, within the FoxP3 þ cells, the CD69 þ subset is the most potent with suppressive capacity in vitro and in vivo. Recent data indicate that CD69 associates with the Jak3/STAT5 pathway, triggering STAT5 phosphorylation [9,13], which can directly bind the Foxp3 promoter, thus playing a critical role in Treg development [16] . STAT5 phosphorylation, which is critical for Treg thymic differentiation, is diminished in Cd69 À/À Tregs and lower strength of TCR or costimulatory signals is required to maintain FoxP3 expression on Tregs, through the inhibition of the AKT/mTOR pathway in a TGF-b independent manner [34, 35] . Moreover, inhibition of the ERK MAPK pathway increases the frequency of FoxP3 þ Tregs in a mechanism dependent on TGF-b signaling [36] . Here we show that, although the AKT pathway and FoxP3 expression at mRNA or protein levels are not altered in the absence of CD69 expression in Tregs, the ERK MAPK pathway remains phosphorylated only in CD69 À/À Treg cells after long term TCR signaling. Since ERK is not active in CD69 þ/þ Tregs, the pretreatment of Tregs during 2 h with ERK inhibitor may be effective only in CD69 À/À Tregs with activated ERK, having no effect on CD69 þ/þ Tregs with down-regulated ERK signaling. Therefore, inhibition of the ERK1/2 pathway in Cd69 À/À Tregs restores their suppressive function in vitro and in vivo [37] . Interestingly, the secretion of TGF-b by CD69-deficient Tregs after TCR stimulation is significantly inhibited, indicating that CD69 exerts its immunoregulatory role through the control of the ERK MAPK pathway in a mechanism dependent on TGF-b. The regulation of the immune response to aeroantigens is critical for maintaining immune tolerance in the lungs and preventing airway inflammatory disease [38] . In a previous work we demonstrated that CD69 expression in effector T cells negatively regulates Th2 and Th17 cell-driven inflammatory responses associated to allergic asthma and contact dermatitis [39] . However, the role of CD69 in the function of regulatory T cells and the maintenance of lung tolerance has not been before explored. Treg subset is central to the maintenance of mucosal tolerance, and defects in the development or function of these cells lead to exacerbated airway inflammation typical of allergies and asthma [14, 40, 41] . Our studies with a model of lung tolerance show that Cd69 À/À Treg cells exhibited a diminished potential to suppress OVA-specific inflammatory responses, indicating that Treg function or migration to the lungs was impaired.
Adoptive transfer experiments unequivocally demonstrate that only the FoxP3 þ CD69 þ Treg subset is able to maintain self tolerance in Cd69 À/À mice. However, in vivo analysis of Treg migration to trachea, alveoli and mediastinal lymph nodes indicates an identical pattern of migration by CD69 þ/þ and Cd69 À/À Tregs. The rate of T cell migration to the inflamed tissue is also regulated by the S1P/ S1P 1 pathway, and it has been demonstrated a role of CD69 in the negative regulation of S1P 1 expression levels in T cells [4, 42] and Dendritic cells [43] . In contrast to our previous observations in CD69 À/À Th17 cells [39] , we have detected any significant difference in S1P 1 expression between Cd69 þ/þ and Cd69 À/À Tregs, suggesting that those are not altered by differential expression of S1P 1 . Moreover, S1P 1 is an inhibitor of Treg cell function through AKT-mTOR pathway [44] and we have not found any differences in this signaling pathway by Cd69 þ/þ and Cd69 À/À Tregs, indicating that CD69 regulation of Tregs function or migration is independent on their expression of S1P 1. white and black symbols indicate mice treated with exogenous Cd69 þ/þ or Cd69 À/À Tregs, respectively. Data are representative of two independent experiments (n ¼ 4e7). *P < 0.05, **P < 0.01, ***P < 0.001.
Conclusions
Several mechanisms of suppression by Tregs have been proposed; however, Tregs need to express CD69 to sustain immune tolerance. Our results thus show that CD69 is a key molecular target for controlling Treg-suppressive function and development of inflammation. The identification of this new subset of CD69 þ Tregs paves the way toward the development of new strategies of Treg cell isolation for therapeutic purposes towards chronic inflammatory and autoimmune diseases.
